New Treatment for Spina Bifida Shows Potential in Improving Children’s Mobility and Quality of Life
A recent clinical trial has revealed that a cutting-edge treatment for spina bifida, a condition in which the spinal cord doesn’t fully develop in the womb, can significantly enhance children’s mobility and quality of life. The procedure involves using stem cells from the mother’s placenta to repair the baby’s spine while still in the womb.
The innovative treatment for spina bifida, a birth defect often leading to lifelong disabilities, was hailed as promising by researchers. This could potentially change the treatment landscape for children born with this developmental disorder.
The groundbreaking treatment was led by Diana Farmer, chair of the University of California’s Davis Department of Surgery. As per her statement, this procedure could pave the path for new treatment options for children born with birth defects.
The first phase of the trial saw the participation of six mothers. The results of the trial, which were unveiled this week, demonstrated the procedure’s potential for success. Among the participating mothers was Michelle Johnson, who shared an inspirational update about her son Tobi, born in 2022.
Johnson expressed immense gratitude for the trial results, stating that her son’s physical and mental abilities post-treatment were nothing short of a miracle.
While further research is still necessary to validate these initial findings, co-inventor of the treatment, Aijun Wang, declared it to be a major step towards a novel kind of fetal therapy. UK-based charity for spina bifida, Shine, referred to these findings as “very exciting”.
Image Courtesy: University of California
